Lite Strategy, Inc. (LITS : NASDAQ)
Common Stock
$1.43
USD
+0.25 (21.19%)
Last updated: 2026-09-24
Follow LITS
LITS
Lite Strategy, Inc.
WealthAwesomePerformance
1 Day
+21.19%
1 Week
+37.50%
1 Month
+36.19%
YTD
+55.43%
Key Statistics
Market Cap
$40.15M
52W High
$2.97
52W Low
$0.69
P/E Ratio
-
50 Day MA
$1.01
200 Day MA
$1.13
Beta
0.04
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/24/2026 | $1.33 | $1.54 | $1.31 | $1.43 | $1.43 | 5,371,411 |
| 9/23/2026 | $1.28 | $1.31 | $1.17 | $1.18 | $1.18 | 585,001 |
| 9/22/2026 | $1.26 | $1.31 | $1.24 | $1.30 | $1.30 | 607,844 |
| 9/21/2026 | $1.20 | $1.33 | $1.08 | $1.28 | $1.28 | 1,606,720 |
| 9/18/2026 | $1.07 | $1.15 | $1.03 | $1.13 | $1.13 | 1,034,300 |
| 9/17/2026 | $1.06 | $1.13 | $1.04 | $1.04 | $1.04 | 904,978 |
| 9/16/2026 | $1.07 | $1.07 | $0.99 | $1.02 | $1.02 | 318,200 |
| 9/15/2026 | $1.14 | $1.17 | $1.05 | $1.09 | $1.09 | 318,100 |
| 9/14/2026 | $1.11 | $1.20 | $1.11 | $1.15 | $1.15 | 329,600 |
| 9/11/2026 | $1.06 | $1.12 | $1.06 | $1.11 | $1.11 | 278,100 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LITS's historical volatility
30-Day Vol
93.6%
Annualized
90-Day Vol
77.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$1.71
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$1.52 | US$1.10 – US$2.10 |
| 60 trading days | US$1.61 | US$1.02 – US$2.54 |
| 90 trading days | US$1.71 | US$0.98 – US$2.99 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-17.13M
- Profit Margin
- 0.00%
- ROE (TTM)
- -159.26%
- EPS (Diluted)
- -1.87
- Book Value
- 1.62
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About LITS.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RPGL | Republic Power Group Limited Class A Ordinary Shares | $14.69 | +1363.23% |
| KITT | Nauticus Robotics Inc. | $2.93 | +459.21% |
| ZWZZT | NASDAQ TEST STOCK | $24.50 | +144.51% |
| SRZN | Surrozen Inc | $33.68 | +108.42% |
| GLND | Greenland Energy Company Common Stock | $5.35 | +83.85% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.65 | +80.62% |
| STAK | STAK Inc. Ordinary Shares | $1.44 | +53.19% |
| PFSA | Profusa, Inc. Common Stock | $3.03 | +47.80% |